A COVID-19 vaccine developed by a multinational pharmaceutical company will be produced by a Korean pharmaceutical company under a CMO deal. The government plans to officially announce the specific company and manufacturing plan in the near future.

Young-Ha Baek, head of vaccine procurement at the pan-government vaccine procurement task force, announced the news today (15th) during the morning briefing.

In a press gaggle, Baek said, “A Korean pharmaceutical company is currently working out the details on a contract manufacturing organization (CMO) deal to produce a COVID-19 vaccine that has been developed abroad. Under the CMO deal, the vaccine will be manufactured in Korea from